Core Viewpoint - Tharimmune, Inc. is rebranding to Canton Strategic Holdings, Inc. to align with its digital asset treasury strategy, marking a significant milestone in its support for institutional adoption of the Canton Network [1] Group 1: Corporate Rebranding - The company will change its name to Canton Strategic Holdings, Inc. effective February 18, 2026, with a new NASDAQ ticker symbol "CNTN" [1] - This rebranding is part of a strategy to digitize traditional financial markets using Canton Coin [1] Group 2: Financial Strategy and Milestones - The company was established in November 2025 through a $545 million private placement to execute a differentiated digital asset treasury strategy [1] - Recent milestones include a $55 million underwritten registered offering to support growth and expansion of its Canton-centric digital asset treasury strategy [1] - The company has deepened institutional expertise on its Board of Directors with the appointments of Former CFTC Commissioner Jill Sommers and DRW Chief of Staff William Wiley [1] Group 3: Institutional Adoption and Ecosystem Development - The company has secured approval to operate a Super Validator on the Canton Network, which is expected to enhance the ecosystem [1] - The company is committed to providing quarterly ecosystem reports to demonstrate its progress and value delivery to shareholders [1] - The Canton Network is positioned to support significant financial transactions, processing $9 trillion in monthly transaction volume [1]

Core Insights - Tharimmune, Inc. has appointed Mark Wendland as Chairman of the Board and Angela Radkowski as Chief Operating Officer to enhance its institutional platform and support the Canton Network's digital asset strategy [1][3] Leadership Changes - Mark Wendland, previously CEO, takes over as Chairman, succeeding Vincent LoPriore, who will remain on the Board [1] - Angela Radkowski's appointment as COO is aimed at overseeing operational control functions and implementing the Canton Network's initiatives [2][3] Strategic Focus - The company aims to modernize financial market infrastructure through its Canton Network-aligned digital asset strategy, which includes acquiring Canton Coin and operating as a Super Validator [3][4] - Tharimmune plans to invest in applications on the Canton Network to enhance institutional utility and adoption in capital markets [4] Company Background - Tharimmune is the first publicly traded company leveraging Canton Coin to support blockchain adoption and digitization of financial markets [5]

Core Insights - Tharimmune, Inc. has appointed Jill Sommers and William Wiley to its Board of Directors to enhance governance as the company advances its Canton Network infrastructure [1][2] Group 1: Board Appointments - Jill Sommers brings nearly three decades of experience in derivatives and financial markets, having served as a Commissioner of the U.S. Commodity Futures Trading Commission (CFTC) and held senior roles in regulatory affairs [2][3] - William Wiley has extensive capital markets experience and has led complex global operations, currently serving as Head of the Equities and Latency Sensitive Business Unit at DRW [3][4] Group 2: Strategic Vision - The company aims to modernize financial infrastructure through its digital asset treasury strategy, leveraging Canton Coin to support the Canton Network [2][4] - Tharimmune intends to invest in applications built on the Canton Network to enhance institutional utility and adoption across capital markets [4] Group 3: Company Overview - Tharimmune is the first publicly traded company to utilize Canton Coin and support the Canton Network, focusing on advancing institutional blockchain adoption and the digitization of financial markets [5]

Summary of Tharimmune, Inc. Special Meeting Company Overview - **Company**: Tharimmune, Inc. (NasdaqCM:THAR) - **Meeting Date**: January 30, 2026 - **Key Participants**: Mark Wendland (CEO), Jacob Asbury (CFO), Francis H. Bird (Inspector of Election) Key Proposals and Votes 1. **Election of Directors** - Two directors nominated: Jill E. Summers and William Wiley - Each nominee's term expires at the next annual meeting - Requires a plurality of votes to be elected - **Outcome**: Approved [12] 2. **Issuance of Shares for Strategic Advisor Warrants** - Proposal to approve issuance of shares upon exercise of Strategic Advisor Warrants - Requires majority vote for approval - **Outcome**: Approved [12] 3. **Issuance of Shares for Cryptocurrency Pre-Funded Warrants** - Proposal related to shares issued in connection with a private placement on November 3, 2025 - Requires majority vote for approval - **Outcome**: Approved [13] 4. **Issuance of Restricted Stock Units to Clear Street, LLC** - Proposal for issuance of restricted stock units and common stock upon settlement - Requires majority vote for approval - **Outcome**: Approved [13] 5. **Amendment to the 2023 Omnibus Equity Incentive Plan** - Proposal to increase the number of shares available for issuance by 7 million shares - Requires majority vote for approval - **Outcome**: Approved [13] 6. **Adjournment of the Meeting** - Proposal to approve adjournments if necessary for further solicitation of votes - Requires majority vote for approval - **Outcome**: Approved [13] Additional Information - **Voting Process**: Shareholders were informed that abstentions would count as votes against the proposals [5][9] - **Quorum**: A quorum of shareholders was present, allowing the meeting to proceed lawfully [3] - **No Questions Submitted**: There were no questions from shareholders during the meeting [11] Conclusion - The special meeting concluded with all proposals being approved, indicating strong shareholder support for the company's strategic initiatives and governance [14]

Core Insights - Tharimmune, Inc. has been approved to operate as a Super Validator on the Canton Network, enhancing its digital asset treasury strategy through contributions to the network [1][5]. Group 1: Company Developments - Tharimmune is the first publicly traded company to utilize Canton Coin to support the Canton Network's digitization of traditional financial markets [1][6]. - The company plans to provide quarterly research on onchain analytics, community development, governance, and tokenomics updates, along with hosting public webinars to engage ecosystem participants [2]. - Tharimmune aims to invest in applications on the Canton Network to promote institutional utility and adoption in capital markets [5]. Group 2: Network and Market Impact - The Canton Network processes over 700,000 daily transactions, amounting to $9 trillion in monthly transaction volume, highlighting its critical role in transforming global financial infrastructure [3]. - The network is increasingly favored by global financial institutions for its programmable privacy features, allowing for instantaneous settlement while maintaining discretion for authorized parties [4]. - The Canton Network's capabilities are expected to unlock greater liquidity for financial markets through atomic settlement [3].

Company Overview - Tharimmune, Inc. (THAR) is a pre-revenue biotech research and development firm with no long-term debt [1] - The company reported annual expenses of $10.3 million and $7.6 million in unspecified revenue [1] Investment Strategy - The investment approach focuses on a diversified portfolio including low-cost index funds, U.S. T-Bills/Treasuries, investment real estate, and a small percentage of individual stocks [1] - Individual stocks are selected for long-term growth potential or to provide higher income compared to real estate investments [1] Current Holdings - Current individual stock holdings include AMZN, TSMC, EPD, TROW, and BMNR, with a long position in all except TROW, where covered calls are consistently sold [1] Analyst's Position - The analyst holds a beneficial long position in THAR through stock ownership, options, or other derivatives [1] - The article reflects the analyst's personal opinions and is not compensated beyond contributions to Seeking Alpha [1]

Core Viewpoint - Tharimmune, Inc. has successfully closed a registered direct offering, raising approximately $55 million to support its digital asset treasury strategy and general corporate purposes [2][3]. Group 1: Offering Details - The offering included the issuance of 1,800,000 shares of common stock at a price of $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares at a price of $2.9199 per warrant [1][2]. - Clear Street acted as the sole bookrunning manager for the offering, with legal counsel provided by Paul Hastings LLP for Clear Street and Reed Smith for Tharimmune [3]. Group 2: Company Overview - Tharimmune, Inc. is the first publicly traded company to utilize Canton Coin, aiming to enhance institutional blockchain adoption and the digitization of financial markets [6]. - The company operates a differentiated digital asset treasury strategy by participating in the Canton Network, which is a secure blockchain hosting trillions in assets [3][6].

Core Viewpoint - Tharimmune, Inc. has completed a $55 million underwritten public offering, issuing 1.8 million shares at $2.92 per share, along with up to 17 million pre-funded warrants [1] Group 1: Financial Details - The company raised funds through the issuance of 1.8 million shares priced at $2.92 each [1] - The total amount raised from the offering is $55 million [1] Group 2: Use of Proceeds - The funds will be used to continue expanding and developing its digital asset treasury strategy centered around the Canton Network [1] - Additionally, the proceeds will support general operational expenses [1] Group 3: Company Position - Tharimmune is the first publicly traded company to utilize Canton Coin and participate in the Canton Network [1]

Core Viewpoint - Tharimmune, Inc. has announced a $55 million registered offering to support its digital asset treasury strategy leveraging the Canton Network, which aims to digitize traditional financial markets [1][2]. Group 1: Offering Details - The offering includes the issuance of 1,800,000 shares of common stock at a price of $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares at a price of $2.9199 per warrant [2]. - The offering is expected to close on or about January 21, 2026, pending customary closing conditions [2]. Group 2: Company Background - Tharimmune, Inc. is the first publicly traded company to utilize Canton Coin and support the Canton Network, focusing on institutional blockchain adoption and the digitization of financial markets [6]. - The company also engages in clinical-stage biotech research and development [6]. Group 3: Underwriting and Registration - Clear Street is acting as the sole bookrunner for the offering [3]. - The securities are being offered under a shelf registration statement filed with the SEC on January 9, 2026, which became effective on January 16, 2026 [4].

Core Insights - Tharimmune, Inc. is the first publicly traded company to utilize Canton Coin to enhance the Canton Network's capability in digitizing traditional financial markets [1][5] - The partnership between DTCC and Digital Asset Holdings aims to tokenize U.S. Treasury securities, representing a significant advancement in blockchain adoption within institutional finance [2][3] Group 1: Institutional Adoption of Blockchain - The collaboration with DTCC signifies a structural shift towards on-chain financial systems, with over $30 trillion in U.S. Treasury assets currently held by DTCC, presenting a unique opportunity for treasury and repo transactions on-chain [2][4] - The Canton Network offers programmable privacy, allowing market participants to achieve instantaneous settlement while maintaining confidentiality regarding trade identities, which is crucial for institutional adoption [3][4] Group 2: Transaction Volume and Growth Strategy - The Canton Network has achieved a monthly transaction volume of $9 trillion, with over 700,000 daily transactions, indicating a robust and growing ecosystem [4] - Tharimmune's digital asset treasury strategy, initiated with a $545 million private placement, aims to support the Canton Network's expansion and long-term development, including acquiring Canton Coin and pursuing roles as a Super Validator [4]